BIOMAT Database Logo BIOMAT Database Logo

Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells. 2001

H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Department of Obstetrics and Gynecology, Ewha Womans University, Seoul, 158-710, Korea.

OBJECTIVE The cadherin/catenin adhesion complex is fundamentally involved in epithelial cancer invasion and metastasis. Much evidence suggesting that epidermal growth factor (EGF) induced the scattering and invasion of cancer cells, probably by affecting E-cadherin function, has been reported. The present study aimed to confirm the hypothesis that EGF/epidermal growth factor receptor (EGFR) was related with the E-cadherin adhesion system in cervical cancer cells and that EGF might induce tyrosine phosphorylation of beta- and gamma-catenin. METHODS Cervical cancer cells were treated for different time durations with 30 ng/ml of EGF. Alteration of the cell morphology was examined by light microscopy and the expression of E-cadherin, beta-catenin, gamma-catenin, EGFR, and activated EGFR was assayed using Western blotting. Tyrosine phosphorylation of beta- and gamma-catenin was also examined using immunoprecipitation. RESULTS E-cadherin and EGFR were expressed in CaSki, HT-3, and ME-180 cell lines, which showed epithelial contact growth. The expression of E-cadherin and beta- and gamma-catenin did not change after treatment with EGF. The expression of EGFR decreased and activated EGFR expression increased in 30 min and then decreased subsequently. The simultaneous expression of activated EGFR and tyrosine phosphorylation of beta- and gamma-catenin was found. CONCLUSIONS EGF-induced scattering of the E-cadherin-positive cervical cancer cells might be the result of tyrosine phosphorylation of the beta- and gamma-catenin. Phosphorylation of the beta- and gamma-catenin may hamper the adhesive function of the E-cadherin-catenin complex.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine

Related Publications

H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells.
January 1995, Biochemical and biophysical research communications,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Clinicopathological significance of E-cadherin, β-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma.
June 2012, Hepato-gastroenterology,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells.
July 2002, Lung cancer (Amsterdam, Netherlands),
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.
December 1997, Laboratory investigation; a journal of technical methods and pathology,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells.
January 1994, Cell adhesion and communication,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
January 1997, Anticancer research,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor.
December 1994, The Journal of cell biology,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.
December 1999, The Journal of biological chemistry,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
The reduced expression of e-cadherin, alpha-catenin and gamma-catenin but not beta-catenin in human lung cancer.
January 1999, Oncology reports,
H S Moon, and E A Choi, and H Y Park, and J Y Choi, and H W Chung, and J I Kim, and W I Park
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
March 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!